1.Short and Long-Term Outcomes of Diabetes Mellitus in Patients with Autoimmune Pancreatitis after Steroid Therapy.
Yuji MIYAMOTO ; Terumi KAMISAWA ; Taku TABATA ; Seiichi HARA ; Sawako KURUMA ; Kazuro CHIBA ; Yoshihiko INABA ; Go KUWATA ; Takashi FUJIWARA ; Hideto EGASHIRA ; Koichi KOIZUMI ; Ryoko SEKIYA ; Junko FUJIWARA ; Takeo ARAKAWA ; Kumiko MOMMA ; Toru ASANO
Gut and Liver 2012;6(4):501-504
BACKGROUND/AIMS: Autoimmune pancreatitis (AIP) is frequently associated with diabetes mellitus (DM). This study evaluated the effect of steroid therapy on the course of DM in AIP. METHODS: Glucose tolerance was examined in 69 patients with AIP. DM onset was classified as either a simultaneous onset with AIP or an exacerbation of pre-existing DM. Based on the changes in the HbA1c levels and insulin dose, the responses of DM to steroids were classified as improved, no change, or worsened. RESULTS: Thirty (46%) patients were diagnosed as having DM (simultaneous onset, n=17; pre-existing, n=13). Three months after starting the steroid treatment, the DM improved in 13 (54%) of 24 DM patients. The DM improved in 55%, had no change in 36%, and worsened in 9% of the 11 simultaneous onset DM patients, and it improved in 54%, had no change in 31%, and worsened in 15% of the 13 pre-existing DM patients. At approximately 3 years after starting the steroid treatment, the DM improved in 10 (63%) of 16 patients. The pancreatic exocrine function improved in parallel with the changes in the DM in seven patients. CONCLUSIONS: Because approximately 60% of DM associated with AIP is responsive to steroids in the short- and long-terms, marked DM associated with AIP appears to be an indication for steroid therapy.
Diabetes Mellitus
;
Glucose
;
Humans
;
Insulin
;
Pancreatitis
;
Steroids
2.Developing a “Multidisciplinary Collaboration Ability Scale (MCAS)”: Examining the Reliability and Validity for Medical Professionals Engaged in Cancer Care
Yukiko IIOKA ; Ryoko OHBA ; Chiho HIROTA ; Miyuki MORIZUMI ; Yumi KOSUGE ; Ikuko MANABE ; Hirokazu KIYOZAKI ; Tomoko BABA ; Daiki SEKIYA ; Yasunori OGURA ; Masatoshi GIKA ; Hisashi KUROSAWA
Palliative Care Research 2023;18(1):1-10
Purpose: The purpose of this study is to develop a “Multidisciplinary Collaboration Ability Scale (MCAS)” and examine the reliability and validity for medical professionals engaged in cancer care. Method: The first MCAS draft was created, and the content validity and surface validity of the scale were examined for medical professionals. Next, a cross-sectional questionnaire survey was conducted on medical professionals engaged in cancer care who worked in medical institutions. Exploratory factor analysis and known-groups technique were carried out, coefficient α calculated, and concurrent validity examined. This study was conducted with the approval of the research ethics review. Result: Exploratory factor analysis resulted in 33 items of 4 factors (ability to promote discussion, foundational relationship building, self-control, and problem-solving activities). The MCAS score was significantly higher for those who had participated in a multidisciplinary workshop and those who had more years of experience. Coefficient α for the entire scale and for each factor was .80 and above. Examination of concurrent validity showed a moderate correlation. Conclusion: The reliability and validity of MCAS in its development stage were generally verified.